Guest guest Posted November 11, 2004 Report Share Posted November 11, 2004 American College of Rheumatology Drug Alerts & Information Methotrexate Availability Reduced Through 12/04 The major producer for the methotrexate injectable, American Pharmaceutical Partners Inc is currently on backorder for production of methotrexate 50 and 200mg, 25mg/ml injectable vials with preservative. The methotrexate without preservative 200mg, 25mg/ml in 8ml size is currently the only injectable that is available through the American Pharmaceutical Partners (APP). The preservative free ingredient for this product is benzyl alcohol and the American Pharmaceutical Partners has advised that if the preservative - free methotrexate is ordered, it should only be used as a single dose as there is no data or research to insure its stability. The senior marketing director for APP has indicated that they are anticipating having the medicine back on the market between the 3rd and 4th week of December. If you have specific questions in regards to the product there is a medical information line, (800) 551-7176, which has a pharmacist available for your questions. Please talk with your wholesale distributor to obtain methotrexate without preservative until production is resumed at the American Pharmaceutical Partners Inc. http://www.rheumatology.org/practice/drugalerts/index.asp I'll tell you where to go! Mayo Clinic in Rochester http://www.mayoclinic.org/rochester s Hopkins Medicine http://www.hopkinsmedicine.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.